Anxiety and depression are more common among people with Crohn’s disease, and they can worsen symptoms. Here’s why and ways ...

This condition goes beyond just causing health anxiety. People with SSD excessively focus on any symptoms they may be ...

We are delighted to welcome Dr. Barbato to Incannex as our Chief Medical Officer. With an established track record in directing drug development through late-stage clinical trials and multiple product ...

The United States Patent and Trademark Office (USPTO) has granted U.S. patent 12,122,741, which claims the composition of ...

You may also need to follow preventive measures to avoid reinfection. Beard: Ringworm in the beard area requires prescription antifungal medicine and a tailor-made treatment plan. Your dermatologist ...

Laser treatment for nail psoriasis: Six treatments, which were given once a month with a pulsed dye laser, lead to noticeably less nail discoloration, crumbling, and pitting. Phototherapy is a ...

Because these treatments are not always apparent to the unpracticed eye, and are sometimes difficult to distinguish even by experts, it is necessary and legally required for anyone selling a gem ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry ...

for the treatment of generalized anxiety disorder, in a Phase 2 trial conducted in the United States and United Kingdom, and IHL-675A, an oral fixed dose combination of cannabidiol and ...

AbbVie and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions.

Looking for smart, simple tips to help keep you healthy? Your Health is a free, monthly e-newsletter from Johns Hopkins Medicine.